Imugene to Receive A$11 Million R&D Tax Refund for FY23 | ASX:IMU, OTC:IUGNF

Proactive Investors12/19 06:12

6 ASX Shares Down 50%+ in 2024. Are They Cheap?

The Motley Fool12/03 12:59

Imugene Doses First Patient in Intratumoral Injection Group of Phase 1 Cancer Trial

MT Newswires11/11 09:42

Five at Five AU: ASX to End Week on a High Note | ASX:IMU, OTC:IUGNF

Proactive Investors11/08 12:31

Why Imugene, Neuren, Sigma, and Smartgroup Shares Are Charging Higher

The Motley Fool11/08 10:13

Imugene Opens First Australian Site for Azer-cel Clinical Trial Targeting Lymphoma | ASX:IMU, OTC:IUGNF

Proactive Investors11/08 08:48